Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.078 5 days ( -9.72 % )
Last Price $1.58 0 %
High/ Low $1.53 - $1.65 23.53%
Chg 7 Days 17.91 % $1.34 $1.58
Chg 30 Days -7.60 % $1.71 $1.58
Chg 12 mos 49.06 % $1.06 $1.58
Trend - 3 mos 102.99 % Width: 39.25 %
Trend - 12 mos -4.84 % Width: 338.69 %
Pred. range - 3 mos $2.89 - $4.02 82.74 % - 154.46 %
Pred. range - 12 mos $0.379 - $1.66 -76.04 % - 5.10 %
Short MA avg 3 mos Buy 2024-03-21 - 6 days
Long MA avg 3 mos Buy 2024-03-21 - 6 days
Short/Long MA avg 3 mos Buy 2024-03-27 - 2 days
Short MA avg 12 mos Buy 2024-03-26 - 3 days
Long MA avg 12 mos Buy 2023-12-26 - 65 days
Short/Long MA avg 12 mos Buy 2024-01-10 - 55 days
Pivot Short Sell 2024-03-08 - 15 days
Bollinger Buy 2023-10-10 - 118 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT